Benjamin J. Zeskind

Insider Reports History

Entity
Individual
Location
C/O Immuneering Corporation, 245 Main Street, Second Floor, Cambridge, MA
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Benjamin J. Zeskind
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin J. Zeskind:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Immuneering Corp PRESIDENT AND CEO, Director, 10%+ Owner Class A Common Stock 2.28M $6.31M $2.77 Mar 19, 2024 Direct
Immuneering Corp PRESIDENT AND CEO, Director, 10%+ Owner Class A Common Stock 895K $2.48M $2.77 Mar 19, 2024 Indirect
Immuneering Corp PRESIDENT AND CEO, Director, 10%+ Owner Stock Option 16.4K Feb 8, 2024 Direct

Insider Reports Filed by Benjamin J. Zeskind

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IMRX Immuneering Corp Mar 19, 2024 1 $55.3K 4 Mar 19, 2024 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Feb 8, 2024 2 $0 4 Feb 9, 2024 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Feb 15, 2023 2 $0 4 Feb 17, 2023 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Dec 22, 2022 2 $7.53K 4 Dec 27, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Apr 12, 2022 2 $6.02K 4 Apr 14, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Mar 23, 2022 1 $24.1K 4 Mar 24, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Feb 28, 2022 2 $6.02K 4 Mar 1, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Feb 10, 2022 2 $0 4 Feb 14, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Dec 31, 2021 2 $0 5 Feb 10, 2022 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Sep 13, 2021 1 $47.6K 4 Sep 14, 2021 PRESIDENT AND CEO, Director, 10%+ Owner
IMRX Immuneering Corp Aug 3, 2021 4 $31.5K 4 Aug 4, 2021 President and CEO, Director, 10%+ Owner
IMRX Immuneering Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 President and CEO, Director, 10%+ Owner